---
title: Lipoic Acid & Migraines
description: The effect of alpha-lipoic acid (ALA) on women with episodic migraines was recently published in the Nature Research journal Scientific Reports. In this randomized and double-blinded trial, 92 women between the ages of 20-50 with episodic migraines (< 15 headache days per month) received either 300mg ALA twice per day or a matching placebo for a period of 3 months. In addition to clinical symptoms, serum levels of lactate, NO (nitric oxide), and VCAM-1 (vascular cell adhesion molecule-1) were included in the analysis.
---

[Research Forum ](https://info.bioticsresearch.com/researchforum)

# [Lipoic Acid & Migraines](https://info.bioticsresearch.com/researchforum/lipoic-acid-migraines)

 Written by [The Biotics Research Team](https://info.bioticsresearch.com/researchforum/author/the-biotics-research-team) | Jul 30, 2022 4:48:52 AM

The effect of alpha-lipoic acid (ALA) on women with episodic migraines [was recently published](https://pubmed.ncbi.nlm.nih.gov/34997178/) in the Nature Research journal *Scientific Reports*. In this randomized and double-blinded trial, 92 women between the ages of 20-50 with episodic migraines (< 15 headache days per month) received either 300 mg ALA twice per day or a matching placebo for a period of 3 months. In addition to clinical symptoms, serum levels of lactate, NO (nitric oxide), and VCAM-1 (vascular cell adhesion molecule-1) were included in the analysis. 

Among the 79 women that completed the trial, a significant reduction in headache severity and frequency was reported (but not duration), along with improvement in indices related to daily performance and well-being. For example, the ALA group had a mean reduction in headache days per month of 2.55 (a nearly 45% decrease) vs. 0.40 (7% decrease) in the control group. After multivariate adjustment, a significant decrease in serum lactate and VCAM-1 was also observed with ALA supplementation, indicating potential improvements in mitochondrial function and endothelial function, respectively. 

This is not the first report of a potential benefit of ALA supplementation for migraineurs. [A 2007 study](https://pubmed.ncbi.nlm.nih.gov/17355494/) at the same dose found a prophylactic effect of ALA, as did [an uncontrolled study](https://pubmed.ncbi.nlm.nih.gov/28976801/) at 800 mg per day.

[View full post](https://info.bioticsresearch.com/researchforum/lipoic-acid-migraines)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "The Biotics Research Team"
  },
  "dateModified" : "2022-08-01T15:30:50.512Z",
  "datePublished" : "2022-07-30T04:48:52Z",
  "headline" : "Lipoic Acid & Migraines",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1414,
    "url" : "https://4004166.fs1.hubspotusercontent-na1.net/hubfs/4004166/iStock-1358208519.jpg",
    "width" : 2120
  },
  "mainEntityOfPage" : "https://info.bioticsresearch.com/researchforum/lipoic-acid-migraines",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Research Forum"
  }
}
```